Myths vs facts: Vitamin D 25-OH and Darmgesundheit

Vitamin D status, measured as serum 25‑OH‑D, is well established in regulating gut immunity and maintaining the mucosal barrier. Deficient vitamin D correlates with increased intestinal permeability, elevated inflammatory markers, and a higher risk of inflammatory bowel diseases such as Crohn’s and ulcerative colitis. A 2016 meta‑analysis found that supplementation modestly reduced disease activity in IBD patients. Experimental models demonstrate that the active metabolite 1,25‑OH₂‑D up‑regulates tight‑junction proteins and suppresses pro‑inflammatory cytokines. However, most evidence derives from limited‑size randomized trials and observational cohorts, leaving a moderate confidence level. Clinically, low‑to‑normal vitamin D alone is not a stand‑alone gastro‑therapy; it should complement dietary, probiotic, and conventional treatment strategies. Marketing claims that 25‑OH‑D directly “optimizes” gut health exceed the current evidence base and should be approached cautiously.